<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about MWIV</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 23 May 2013 06:18:55 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=MWIV" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484">
      <guid isPermaLink="false">243484</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n8O-BTQz7Ms/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>MWI Vet Earnings Beat, Sales Miss - Analyst Blog</title>
      <description>MWI Veterinary Supply  (  MWIV  ) reported second-quarter fiscal 2013 earnings per share (EPS) of $1.19, up 4.4% on a year-over-year basis. The result also surpassed the Zacks Consensus&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/n8O-BTQz7Ms" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 20:44:45 Z</pubDate>
      <a10:updated>2013-05-03T17:34:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/becton-beats-earnings-guides-high-analyst-blog-cm243213">
      <guid isPermaLink="false">243213</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uhlp2A-C9EQ/becton-beats-earnings-guides-high-analyst-blog-cm243213</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Becton Beats Earnings, Guides High  - Analyst Blog</title>
      <description>Medical technology major  , Becton, Dickinson and Company  (  BDX  ) reported second-quarter fiscal 2013 adjusted earnings per share from continuing operations of $1.44, beating the Zacks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Uhlp2A-C9EQ" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 22:25:29 Z</pubDate>
      <a10:updated>2013-05-02T20:34:22Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>WST</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/becton-beats-earnings-guides-high-analyst-blog-cm243213</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/got-growth-cm243175">
      <guid isPermaLink="false">243175</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lMa07zDjw9Q/got-growth-cm243175</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Got Growth?</title>
      <description>With first-quarter U.S. GDP growth falling short of expectations and few expecting much in the way of broader economic growth for the rest of the year, investors are once again considering a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/lMa07zDjw9Q" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 21:00:00 Z</pubDate>
      <a10:updated>2013-05-02T18:24:52Z</a10:updated>
      <author>John Reese</author>
      <nasdaq:tickers>EPAM</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>PNRA</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
      <nasdaq:tickers>SYNT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/got-growth-cm243175</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/conmed-1q-earnings-beat-sales-lag-analyst-blog-cm241185">
      <guid isPermaLink="false">241185</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bUrOTWFjMEE/conmed-1q-earnings-beat-sales-lag-analyst-blog-cm241185</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>CONMED 1Q Earnings Beat; Sales Lag - Analyst Blog</title>
      <description>CONMED Corporation  's (  CNMD  ) first-quarter 2013 adjusted earnings per share (excluding one-time expenses) of 45 cents were in line with the Zacks Consensus Estimate. The company also&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/bUrOTWFjMEE" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 26 Apr 2013 22:21:28 Z</pubDate>
      <a10:updated>2013-04-26T20:29:39Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CNMD</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>TRNX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/conmed-1q-earnings-beat-sales-lag-analyst-blog-cm241185</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bard-beats-on-1q-earnings-profit-slumps-analyst-blog-cm240004">
      <guid isPermaLink="false">240004</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O8KGr5lWhd8/bard-beats-on-1q-earnings-profit-slumps-analyst-blog-cm240004</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Bard Beats on 1Q Earnings, Profit Slumps - Analyst Blog</title>
      <description>CR Bard Inc.  's (  BCR  ) first-quarter 2013 adjusted earnings of $1.44 per share beat the Zacks Consensus Estimate by a penny. Adjusted earnings exclude one-time items such as&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/O8KGr5lWhd8" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 24 Apr 2013 17:09:52 Z</pubDate>
      <a10:updated>2013-04-24T14:16:06Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BCR</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>TRNX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bard-beats-on-1q-earnings-profit-slumps-analyst-blog-cm240004</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/test-menu-expansion-by-labcorp-analyst-blog-cm233382">
      <guid isPermaLink="false">233382</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u9bHsVNgcDs/test-menu-expansion-by-labcorp-analyst-blog-cm233382</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Test Menu Expansion by LabCorp - Analyst Blog</title>
      <description>Laboratory Corporation of America Holdings  (  LH  ) recently launched an expanded testing menu to diagnose, treat and evaluate the course of Inflammatory Bowel Disease (IBD). The expanded&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/u9bHsVNgcDs" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 03 Apr 2013 23:21:01 Z</pubDate>
      <a10:updated>2013-04-03T20:22:14Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>LH</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/test-menu-expansion-by-labcorp-analyst-blog-cm233382</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mwi-vet-retained-at-neutral-analyst-blog-cm232430">
      <guid isPermaLink="false">232430</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QlnPKGYise0/mwi-vet-retained-at-neutral-analyst-blog-cm232430</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>MWI Vet Retained at Neutral - Analyst Blog</title>
      <description>On Mar 28, 2013, we reaffirmed our long-term Neutral recommendation on  MWI Veterinary Supply  (  MWIV  ) following the strong first-quarter fiscal 2013 results. This leading distributor of&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/QlnPKGYise0" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 01 Apr 2013 23:10:17 Z</pubDate>
      <a10:updated>2013-04-01T20:13:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>HSIC</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mwi-vet-retained-at-neutral-analyst-blog-cm232430</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/abaxis-pinned-at-neutral-analyst-blog-cm232415">
      <guid isPermaLink="false">232415</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fEXrEt6FS4U/abaxis-pinned-at-neutral-analyst-blog-cm232415</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Abaxis Pinned at Neutral - Analyst Blog</title>
      <description>On Mar 28, we reiterated our long-term Neutral recommendation on  Abaxis Inc.  (  ABAX  ) following healthy third quarter fiscal 2013 results. This manufacturer of portable blood analysis&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fEXrEt6FS4U" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 01 Apr 2013 23:06:38 Z</pubDate>
      <a10:updated>2013-04-01T20:12:28Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABAX</nasdaq:tickers>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>HSIC</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/abaxis-pinned-at-neutral-analyst-blog-cm232415</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/hsic-discusses-2013-biz-environment-analyst-blog-cm226880">
      <guid isPermaLink="false">226880</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y8t1QsHUNQE/hsic-discusses-2013-biz-environment-analyst-blog-cm226880</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>HSIC Discusses 2013 Biz Environment - Analyst Blog</title>
      <description>Recently,  Henry Schein  (  HSIC  ) reviewed its 2012 performance, discussed competitive dynamics and current business environment during the Barclays Global Healthcare Conference.  The company&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/y8t1QsHUNQE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 14 Mar 2013 00:12:36 Z</pubDate>
      <a10:updated>2013-03-13T21:18:37Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>HSIC</nasdaq:tickers>
      <nasdaq:tickers>MCK</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hsic-discusses-2013-biz-environment-analyst-blog-cm226880</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/henry-schein-excels-estimates-analyst-blog-cm217814">
      <guid isPermaLink="false">217814</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LMfF3wIdSH4/henry-schein-excels-estimates-analyst-blog-cm217814</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Henry Schein Excels Estimates - Analyst Blog</title>
      <description>Henry Schein Inc  . (  HSIC  ) reported  earnings per share (EPS) of $1.26 in the fourth quarter of 2012,  reflecting a beat of 5% over the Zacks Consensus Estimate. The  result also&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LMfF3wIdSH4" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 14 Feb 2013 20:20:01 Z</pubDate>
      <a10:updated>2013-02-14T17:55:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>HSIC</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>PDCO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/henry-schein-excels-estimates-analyst-blog-cm217814</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mwi-vet-beats-with-ease-in-1q13-analyst-blog-cm214623">
      <guid isPermaLink="false">214623</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F1dkSY-bNec/mwi-vet-beats-with-ease-in-1q13-analyst-blog-cm214623</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>MWI Vet Beats with Ease in 1Q13 - Analyst Blog</title>
      <description>MWI Veterinary Supply Inc.  (  MWIV  ) reported first-quarter fiscal 2013 EPS of $1.32, up 25.7% on a year-over-year basis. The result also surpassed the Zacks Consensus Estimate by 10.9%,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/F1dkSY-bNec" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 Feb 2013 20:00:01 Z</pubDate>
      <a10:updated>2013-02-06T16:53:20Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mwi-vet-beats-with-ease-in-1q13-analyst-blog-cm214623</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-earnings-report-for-february-4-2013-spg-syy-hum-clx-gold-rcl-tdg-gci-mcy-sohu-mwiv-bhe-cm213321">
      <guid isPermaLink="false">213321</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H3AjeBhbIy4/premarket-earnings-report-for-february-4-2013-spg-syy-hum-clx-gold-rcl-tdg-gci-mcy-sohu-mwiv-bhe-cm213321</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>Pre-Market Earnings Report for February 4, 2013 :  SPG, SYY, HUM, CLX, GOLD, RCL, TDG, GCI, MCY, SOHU, MWIV, BHE</title>
      <description>The following companies are expected to report earnings prior to market open on 02/04/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Simon Property Group,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/H3AjeBhbIy4" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 02 Feb 2013 02:00:04 Z</pubDate>
      <a10:updated>2013-02-01T21:20:04Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BHE</nasdaq:tickers>
      <nasdaq:tickers>CLX</nasdaq:tickers>
      <nasdaq:tickers>GCI</nasdaq:tickers>
      <nasdaq:tickers>GOLD</nasdaq:tickers>
      <nasdaq:tickers>HUM</nasdaq:tickers>
      <nasdaq:tickers>MCY</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>RCL</nasdaq:tickers>
      <nasdaq:tickers>SOHU</nasdaq:tickers>
      <nasdaq:tickers>SPG</nasdaq:tickers>
      <nasdaq:tickers>SYY</nasdaq:tickers>
      <nasdaq:tickers>TDG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-earnings-report-for-february-4-2013-spg-syy-hum-clx-gold-rcl-tdg-gci-mcy-sohu-mwiv-bhe-cm213321</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/abaxis-surpasses-estimates-in-3q-analyst-blog-cm213315">
      <guid isPermaLink="false">213315</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MUAhfXC9Mc/abaxis-surpasses-estimates-in-3q-analyst-blog-cm213315</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Abaxis Surpasses Estimates in 3Q - Analyst Blog</title>
      <description>Provider of portable blood analysis systems for human and veterinary patient-care,  Abaxis Inc.  (  ABAX  ) reported third quarter fiscal 2013 earnings per share (EPS) of 22 cents, a beat of&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/3MUAhfXC9Mc" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 02 Feb 2013 00:40:01 Z</pubDate>
      <a10:updated>2013-02-01T21:24:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABAX</nasdaq:tickers>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/abaxis-surpasses-estimates-in-3q-analyst-blog-cm213315</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mwi-vet-closes-buyout-analyst-blog-cm203357">
      <guid isPermaLink="false">203357</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iGexY-Z-h6A/mwi-vet-closes-buyout-analyst-blog-cm203357</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>MWI Vet Closes Buyout  - Analyst Blog</title>
      <description>In a concerted effort to strengthen its market position,  MWI Veterinary Supply Inc.  (  MWIV  ) recently closed the acquisition of all the assets of Prescription Containers Inc. for about $17&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/iGexY-Z-h6A" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 02 Jan 2013 18:20:01 Z</pubDate>
      <a10:updated>2013-01-02T15:05:12Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>HSIC</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mwi-vet-closes-buyout-analyst-blog-cm203357</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/webster-adopts-pattersons-name-analyst-blog-cm202830">
      <guid isPermaLink="false">202830</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qbNrxaVoQBQ/webster-adopts-pattersons-name-analyst-blog-cm202830</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Webster Adopts Patterson's Name - Analyst Blog</title>
      <description>In a ploy to further popularize its Webster Veterinary Supply unit,  Patterson Companies Inc.  (  PDCO  ) announced that the former will be known as Patterson Veterinary Supply from January 1,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qbNrxaVoQBQ" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 29 Dec 2012 01:50:01 Z</pubDate>
      <a10:updated>2012-12-28T22:43:07Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
      <nasdaq:tickers>PDCO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/webster-adopts-pattersons-name-analyst-blog-cm202830</feedburner:origLink></item>
  </channel>
</rss>
